Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

MGI Pharma and MethylGene to collaborate on DNA MeTase inhibitor development

Aug. 16, 2000

New farnesyl protein transferase inhibitors useful for various tumors

Aug. 11, 2000

Theratechnologies to begin PDT trial in Canada

Aug. 11, 2000

EPTTCO and Onyx establish agreement for anticancer agents

Aug. 11, 2000

New compounds from Novartis useful for proliferative diseases

Aug. 10, 2000

Licensing opportunity from NIH: copper complexes

Aug. 10, 2000

New polypeptides useful for treatment of metastases

Aug. 9, 2000

New antiangiogenic agents under development at Merck KGaA

Aug. 9, 2000

Novel growth factor receptor inhibitors described by Sugen

Aug. 9, 2000

Genasense receives orphan drug status for treatment of malignant melanoma

Aug. 9, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...